Home/Filings/4/0001415889-25-023591
4//SEC Filing

Ticho Barry 4

Accession 0001415889-25-023591

CIK 0001623526other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 5:53 PM ET

Size

5.4 KB

Accession

0001415889-25-023591

Insider Transaction Report

Form 4
Period: 2025-09-02
Ticho Barry
CHIEF MEDICAL OFFICER
Transactions
  • Sale

    Common Stock

    2025-09-02$19.87/sh5,501$109,32518,469 total
Footnotes (2)
  • [F1]The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.54 to $20.34 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother

Related Parties

1
  • filerCIK 0001780088

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:53 PM ET
Size
5.4 KB